Last reviewed · How we verify

NCT05584215: CBTp

Cognitive Behavioural Therapy-Informed Groups for Psychosis

Withdrawn NA Last updated 9 October 2024
What this trial tests

NA trial testing Cognitive Behavioural Therapy for Psychosis Groups in Psychosis. Withdrawn.

Timeline
3 June 2023
Primary endpoint
2 January 2024
2 January 2024

Quick facts

Lead sponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Start date3 June 2023
Primary completion2 January 2024
Estimated completion2 January 2024

Drugs / interventions tested

Conditions studied

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

Adults 18 to 65, any sex, with Psychosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a feasibility study of cognitive behavioural therapy-informed groups for psychiatric inpatients with positive symptoms of psychosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Psychosis

Currently open trials in the same condition.

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05584215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing